The Evolving Reimbursement Landscape – Considerations for Clinical Trial Design


As a guest contributor to Clinical Leader, Precision for Value’s Dominic Galante examines the importance of payer perspective during clinical R&D. With a greater push for evidence-based value, scientists are starting to incorporate payer insights earlier in drug development.

To read the full article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.